A proteome-scale reverse screening approach reveals multi-target interactions of anthraquinone derivatives in cancer-related pathways.
This integrative computational framework combines proteome-scale target discovery, pathway prioritization, structural validation, molecular dynamics, and ADMET evaluation to provide a systems-level perspective on the potential multi-target anticancer mechanisms of anthraquinone derivatives and identify candidate target...